Les différents interférons : Pharmacologie, mécanismes d'action, tolérance et effets secondaires
Author:
- 1 November 2002
- journal article
- review article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 23, 449S-458S
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferon alpha et auto-immunitéLa Revue de Médecine Interne, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis CAdvanced Drug Delivery Reviews, 2002
- PML, un nouvel intermédiaire de l’effet antiviral de l’interféronmédecine/sciences, 2002
- Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and ToxicitiesThe Oncologist, 2001
- Development of Pegylated Interferons for the Treatment of Chronic Hepatitis CBioDrugs, 2001
- Peginterferon-??-2a (40kD)Drugs, 2001
- PegylationClinical Pharmacokinetics, 2001
- Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy dataClinical Pharmacology & Therapeutics, 2000
- Endocrine and neurological adverse effects of the therapeutic interferonsToxicology, 2000